HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Usefulness of sublingual isosorbide to assess the reversibility of pulmonary hypertension in cardiac transplant candidates].

AbstractBACKGROUND:
Continuous infusion of short life vasodilators are employed to test reversibility of pulmonary hypertension in cardiac transplant candidates. Sublingual isosorbide administration has not been described in the literature and it might be a simpler alternative.
AIM:
To evaluate sublingual isosorbide administration as a test of reversibility of pulmonary hypertension in heart failure.
PATIENTS AND METHODS:
Prospective evaluation of patients referred for cardiac transplant evaluation. Patients underwent right catheterization for hemodynamic measurements at baseline and after repeated doses of 5 mg sublingual isosorbide every 5 minutes until observing a decrease in pulmonary vascular resistance decrease or symptomatic hypotension.
RESULTS:
Twenty one patients, 18 men, age 49+/-15 years, were studied. Fourteen (66%) were transplanted. The mean sublingual isosorbide dose was 15+/-5 mg. After isosorbide administration, there was a significant decrease in mean arterial pressure (80+/-8.5 to 71+/-6.6 mmHg, p <0.0001), mean pulmonary artery pressure (38+/-11 to 26+/-7.8 mmHg, p <0.0001), systemic vascular resistance (1540+/-376 to 1277+/-332 dyn*s/cm5 p <0.001), pulmonary vascular resistance (3.5+/-2.2 to 2,5+/-1.6 Wood Units, p <0.05) and transpulmonary gradient (13+/-7 a 10+/-4 mmHg, p <0.004). The cardiac output increased from 3.96+/-0.7 to 4.38+/-0.9 L/min, p=0.05. The relation between pulmonary and systemic vascular resistance before and after isosorbide was 0.17 and 0.15, respectively (p=0.04). One transplanted patient with partial reversibility of pulmonary hypertension developed acute right heart failure.
CONCLUSIONS:
Sublingual isosorbide administration is useful and well tolerated to evaluate the reversibility of pulmonary hypertension prior cardiac transplant.
AuthorsFernando Baraona, Pablo Castro, Osvaldo Pérez, Sergio Morán, Ricardo Zalaquett, Manuel J Irarrázabal, Jorge Jalil
JournalRevista medica de Chile (Rev Med Chil) Vol. 134 Issue 2 Pg. 201-6 (Feb 2006) ISSN: 0034-9887 [Print] Chile
Vernacular TitleUtilidad de isosorbide sublingual en la reversibilidad de la hipertensión pulmonar reactiva, en pacientes candidatos a trasplante cardíaco.
PMID16554928 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Diuretics, Osmotic
  • Vasodilator Agents
  • Isosorbide
Topics
  • Administration, Sublingual
  • Cardiac Catheterization
  • Cardiac Output, Low (etiology, surgery)
  • Diuretics, Osmotic (administration & dosage)
  • Female
  • Heart Transplantation
  • Humans
  • Hypertension, Pulmonary (drug therapy)
  • Isosorbide (administration & dosage)
  • Male
  • Middle Aged
  • Prospective Studies
  • Vasodilator Agents (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: